Free Trial
NASDAQ:YI

111 Q3 2025 Earnings Results & Report

111 logo
$3.09 -0.02 (-0.64%)
Closing price 03:59 PM Eastern
Extended Trading
$3.08 -0.01 (-0.29%)
As of 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

111 reported Q3 2025 earnings on December 17, 2025. The company reported EPS of -$1.20, while revenue was $421.49 million.

Earnings Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call
12:00 AM ET

111 EPS Results

Actual EPS
-$1.20
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

111 Revenue Results

Actual Revenue
$421.49 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

111's Q3 2026 earnings is estimated for Thursday, November 26, 2026, based on past reporting schedules

Earnings Documents

111 Q3 2025 Earnings FAQ

111 (NASDAQ:YI) reported earnings of -$1.20 per share for Q3 2025. The report was announced on Wednesday, December 17, 2025.

111 reported revenue of $421.49 million for Q3 2025.

111's next earnings date is estimated for Thursday, November 26, 2026. MarketBeat tracks confirmed and estimated earnings dates for 111 on the company's earnings history page.

111 Earnings Headlines

Critical Contrast: Tempus AI (NASDAQ:TEM) and 111 (NASDAQ:YI)
111, Inc. Announces Establishment of Special Committee
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
111, Inc. Announces Establishment of the Special Committee
111, Inc Q2 Loss Widens From Lower Revenue; Shares Up
See More 111 Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 111? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 111 and other key companies, straight to your email.

About 111

111 (NASDAQ:YI), Inc. (NASDAQ: YI) is a China-based technology-enabled healthcare platform that connects consumers, healthcare providers, pharmacies and pharmaceutical companies. The company focuses on improving access to healthcare products and services through digital tools and an integrated online and offline operating model.

Its business activities include online retailing and distribution of prescription and over-the-counter medicines, health products, medical devices and other healthcare-related goods. Through its digital platforms, 111 also provides medication information, health-management resources and other services intended to support consumers and healthcare professionals.

111 serves customers and business partners primarily in China. The company was founded in 2010 and has developed operations spanning consumer healthcare, pharmaceutical distribution and technology services. Its platforms are designed to connect pharmaceutical manufacturers with hospitals, pharmacies, clinics and individual consumers across the Chinese healthcare market.

111, Inc. was co-founded by Junling Liu, who has served as the company’s chief executive officer. The company completed its initial public offering on the Nasdaq Stock Market in 2018.

View 111 Profile